Real-world outcomes of newly diagnosed multiple myeloma patients treated with front-line daratumumab bortezomib lenalidomide and dexamethasone.
Parrondo RD, De Menezes R, Sledge H, Nayyar M, Yadav K, Bergsagel L, Fonseca R, Kapoor P, Buadi F, Gertz MA, Dispenzieri A, Roy V, Sher T, Binder M, Abdallah N, Chhabra S, Rajkumar VS, Gonsalves WI, Cook J, Dingli D, Lin Y, Fernandez A, Flott C, Yadav U, Warsame RM, Wiedmeier-Nutor EE, Kourelis T, Leung N, Siddiqui MA, Kumar S, Chanan-Khan AA, Ailawadhi S.
Parrondo RD, et al. Among authors: nayyar m.
Haematologica. 2026 Mar 5. doi: 10.3324/haematol.2025.300401. Online ahead of print.
Haematologica. 2026.
PMID: 41784017
Free article.